Local immune effector cell-associated toxicity syndrome in CAR T-cell treated patients with autoimmune disease: an observational studyMelanie Hagen, Georg Schett, Silvia Spoerl et al.|The Lancet Rheumatology|2025Cited by 71
Comparison of the safety profiles of CD19-targeting CAR T-cell therapy in patients with SLE and B-cell lymphomaFabian Müller, Simon Völkl, Nora Rebecca Schwingen et al.|Blood|2025Cited by 27